BIOSYNERGY INC Net Change in Cash
BIOSYNERGY INC reported Net Change in Cash of $1.23 million for the 9-month period ending 2022-01-31, per its 10-Q/A filed 2022-03-28.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2022-03-28
- BIOSYNERGY INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-07-31 was $46.59K, a 392.76% increase year-over-year.
- BIOSYNERGY INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-07-31 was $9.45K.
- BIOSYNERGY INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $5.30K, a 91.87% decline from fiscal 2020.
- BIOSYNERGY INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $65.16K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-01-31 | $1.23M 10-Q/A · filed 2022-03-28 | |||
| 2021-10-31 | -$162.80K 10-Q · filed 2021-12-15 | |||
| 2021-07-31 | $46.59K 10-Q · filed 2021-09-14 | |||
| 2021-04-30 | $5.30K 10-K · filed 2021-07-29 | |||
| 2021-01-31 | $38.07K 10-Q/A · filed 2022-03-28 | |||
| 2020-10-31 | $14.86K 10-Q · filed 2021-12-15 | |||
| 2020-07-31 | $9.45K 10-Q · filed 2021-09-14 | |||
| 2020-04-30 | $65.16K 10-K · filed 2021-07-29 |